Onramp Invest, Inc.

SAN DIEGO, CA · Founded 2018 · CIK 0001840492 · Biotech

ROSALIND®, a bioinformatics analysis platform for visualizing and analyzing life science research data

rosalind.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$5.0M
3 Form D · May 2022
52 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$150,000
Private capital raisedForm D · SEC$800,000
Private capital raisedForm D · SEC$4,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1919CAMBRIDGE TECHNOLOGIES LLC—$3.5M
1920ONCOTHERAPY SOLUTIONS, LLC——
1921WILD MICROBES CO——
1922Onramp Invest, Inc.—$5.0M
1923Immunocore——
1924MOGLING BIO INC——
1925Arch Innotek, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • Ashton ChaffeeExecutive Officer
  • Nathan DixonExecutive Officer
  • Eric ErvinDirector · Executive Officer
  • Chris HaleyDirector
  • Kasey PriceExecutive Officer
  • Tyrone RossExecutive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.